Treatment of the metastatic melanoma cell line SK-MEL-1, which expressed very low levels of TET2 and TET3 (Supplementary Figure S2), with LY9702161, elevated their expression levels (Figure 1F). Here, TET3 is linked to metastatic melanoma.